These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17664375)

  • 1. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment.
    Airoldi F; Colombo A; Morici N; Latib A; Cosgrave J; Buellesfeld L; Bonizzoni E; Carlino M; Gerckens U; Godino C; Melzi G; Michev I; Montorfano M; Sangiorgi GM; Qasim A; Chieffo A; Briguori C; Grube E
    Circulation; 2007 Aug; 116(7):745-54. PubMed ID: 17664375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
    Kimura T; Morimoto T; Nakagawa Y; Tamura T; Kadota K; Yasumoto H; Nishikawa H; Hiasa Y; Muramatsu T; Meguro T; Inoue N; Honda H; Hayashi Y; Miyazaki S; Oshima S; Honda T; Shiode N; Namura M; Sone T; Nobuyoshi M; Kita T; Mitsudo K;
    Circulation; 2009 Feb; 119(7):987-95. PubMed ID: 19204304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of bleeding and compliance on prolonged dual antiplatelet therapy (aspirin + thienopyridine) following drug-eluting stent implantation.
    Latib A; Morici N; Cosgrave J; Airoldi F; Godino C; Brambilla N; Chieffo A; Bonizzoni E; Carlino M; Bedogni F; Montorfano M; Sangiorgi GM; Briguori C; Colombo A
    Am J Cardiol; 2008 Dec; 102(11):1477-81. PubMed ID: 19026299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
    Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D
    J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent thrombosis after successful sirolimus-eluting stent implantation.
    Jeremias A; Sylvia B; Bridges J; Kirtane AJ; Bigelow B; Pinto DS; Ho KK; Cohen DJ; Garcia LA; Cutlip DE; Carrozza JP
    Circulation; 2004 Apr; 109(16):1930-2. PubMed ID: 15078797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.
    Kuchulakanti PK; Chu WW; Torguson R; Ohlmann P; Rha SW; Clavijo LC; Kim SW; Bui A; Gevorkian N; Xue Z; Smith K; Fournadjieva J; Suddath WO; Satler LF; Pichard AD; Kent KM; Waksman R
    Circulation; 2006 Feb; 113(8):1108-13. PubMed ID: 16490815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents.
    Eisenberg MJ; Richard PR; Libersan D; Filion KB
    Circulation; 2009 Mar; 119(12):1634-42. PubMed ID: 19289638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.
    Wenaweser P; Daemen J; Zwahlen M; van Domburg R; Jüni P; Vaina S; Hellige G; Tsuchida K; Morger C; Boersma E; Kukreja N; Meier B; Serruys PW; Windecker S
    J Am Coll Cardiol; 2008 Sep; 52(14):1134-40. PubMed ID: 18804739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
    Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
    Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation.
    Rossini R; Capodanno D; Lettieri C; Musumeci G; Nijaradze T; Romano M; Lortkipanidze N; Cicorella N; Biondi Zoccai G; Sirbu V; Izzo A; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2011 Jan; 107(2):186-94. PubMed ID: 21211596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
    Flores-Ríos X; Marzoa-Rivas R; Abugattás-de Torres JP; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A
    Am Heart J; 2008 Apr; 155(4):648-53. PubMed ID: 18371471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient.
    Cross J
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S48-53. PubMed ID: 19355809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents.
    Ko DT; Chiu M; Guo H; Austin PC; Marquis JF; Tu JV
    Am Heart J; 2009 Oct; 158(4):592-598.e1. PubMed ID: 19781419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
    J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial.
    Dangas GD; Claessen BE; Mehran R; Xu K; Stone GW
    EuroIntervention; 2013 Jan; 8(9):1033-9. PubMed ID: 23339809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT study.
    Zhu ZB; Zhang RY; Zhang Q; Zhang JS; Hu J; Yang ZK; Shen WF
    Cardiology; 2009; 112(3):191-9. PubMed ID: 18682662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
    Iakovou I; Schmidt T; Bonizzoni E; Ge L; Sangiorgi GM; Stankovic G; Airoldi F; Chieffo A; Montorfano M; Carlino M; Michev I; Corvaja N; Briguori C; Gerckens U; Grube E; Colombo A
    JAMA; 2005 May; 293(17):2126-30. PubMed ID: 15870416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A more than 2-year follow-up of incomplete apposition after drug-eluting stent implantation.
    Qian JY; Zhang F; Fan B; Ge L; Wang QB; Ge JB
    Chin Med J (Engl); 2008 Mar; 121(6):498-502. PubMed ID: 18364132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.